| Literature DB >> 35665243 |
Julio Sotelo1,2,3,4, Pamela Franco2,3,4,5, Andrea Guala6, Lydia Dux-Santoy6, Aroa Ruiz-Muñoz6, Arturo Evangelista6, Hernan Mella2,4,5, Joaquín Mura4,7, Daniel E Hurtado4,8,9, José F Rodríguez-Palomares6, Sergio Uribe2,3,4,9,10.
Abstract
Background and Purpose: Prognostic models based on cardiovascular hemodynamic parameters may bring new information for an early assessment of patients with bicuspid aortic valve (BAV), playing a key role in reducing the long-term risk of cardiovascular events. This work quantifies several three-dimensional hemodynamic parameters in different patients with BAV and ranks their relationships with aortic diameter. Materials andEntities:
Keywords: 4D flow CMR; Bicuspid aortic valve; aneurysm; congenital heart disease; finite elements; hemodynamics parameters; magnetic resonance imaging (MRI); vascular disease
Year: 2022 PMID: 35665243 PMCID: PMC9157575 DOI: 10.3389/fcvm.2022.885338
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
Figure 1Summary of the quantification process. (A) From the 4D-flow CMR acquisition, a semiautomatic segmentation of the aorta was generated and transformed into a tetrahedral mesh. Then, 4D-flow CMR velocity values were interpolated to each node of the mesh, and (B,C) 3D maps of 17 hemodynamics parameters and the diameter were calculated using finite elements. (D) A total of 16 different regions of the aorta were created to compare the data between volunteers and patients.
Volunteer and patient demographics.
|
|
|
| |
|---|---|---|---|
|
|
| ||
| Male/female | 29/19(60%) | 43/31(72%) | 0.470 |
| Age (years) | 41 [30–49] | 45 [37–61] | 0.008 |
| Weight (Kg) | 73.0[64.8–80.0] | 73.5[61.8–80.0] | 0.856 |
| Height (cm) | 169.5[163.0–175.0] | 170.0[163.0–178.0] | 0.929 |
| BSA (m2) | 1.9[1.7–1.9] | 1.9[1.7–2.0] | 0.953 |
| Stroke volume (ml) | 88.1[77.5–114.6] | 92.9[68.9–111.1] | 0.805 |
| Ejection fraction (%) | 66.6[62.6–69.7] | 59.4[55.2–63.6] | 0.000 |
| Phenotype | – | 49RL, 25RN | – |
| Morphotype | – | 25 Non-AAo-D (18 Non-D and 7 Root-D), 49 AAo-D | – |
| Hypertension | – | 30(No), 44(Yes) | – |
Statistically significant differences (p < 0.05);
Chi-square test.
Figure 2Three-dimensional maps of a representative HV and patients with BAV. Columns represent each analyzed parameter (Figure 1C). First row shows a HV, second row a non-dilated BAV (BAV-Non-AAoD) patient, and third row a patient with BAV with ascending aorta dilation (BAV-AAoD).
Figure 3Statistical differences between groups: (A) HV vs. all BAV; (B) HV vs. BAV-RL; (C) HV vs. BAV-RN; (D) HV vs. BAV-Non-AAoD; (E) HV vs. BAV-AAoD. Yellow marks highlight statistically significant differences between compared groups (p-value <0.05). The minus sign in yellow boxes indicates the value was lower in BAV than in volunteers.
Mean and (standard deviation) for each parameter in the AAo section (regions 1 to 4).
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
|
|
|
|
| ||
| Diameter [cm] | 2.87(0.39) | 4.06(0.70) | 4.04(0.73) | 4.10(0.63) | 4.34(0.60) | 3.50(0.53) |
| Eccentricity [%] | 18.76(8.08) | 41.02(13.56) | 40.26(14.20) | 42.51(12.14) | 42.65(13.02) | 37.83(14.10) |
| Velocity [m/s] | 0.41(0.14) | 0.43(0.10) | ||||
| Forward velocity [m/s] | 0.39(0.14) | |||||
| Backward velocity [m/s] | 0.00(0.00) | 0.03(0.02) | 0.03(0.02) | 0.03(0.03) | 0.03(0.02) | 0.02(0.02) |
| Velocity angle [°] | 17.79(7.10) | 51.05(15.91) | 48.54(16.67) | 55.97(13.03) | 56.24(12.90) | 40.88(16.38) |
| Regurgitation fraction [%] | 13.37(8.46) | 41.50(21.81) | 41.73(25.35) | 41.05(12.28) | 44.09(15.34) | 36.43(30.23) |
| WSS [N/m2] | 0.64(0.25) | 0.65(0.22) | ||||
| WSSA [N/m2] | 0.60(0.26) | |||||
| WSSC [N/m2] | 0.14(0.06) | 0.29(0.14) | 0.27(0.12) | 0.31(0.17) | 0.28(0.14) | 0.29(0.13) |
| OSI [–] | 0.17(0.05) | 0.17(0.04) | 0.17(0.04) | 0.17(0.04) | 0.18(0.05) | |
| Vorticity [1/s] | 62.76(17.72) | 72.17(23.24) | 70.40(23.20) | 75.65(23.04) | 68.36(23.43) | 79.65(21.05) |
| Axial vorticity [1/s] | 3.30(9.47) | 17.38(12.90) | 17.86(10.15) | 16.45(17.08) | 16.48(11.14) | 19.14(15.70) |
| Axial circulation [cm2/s] | 27.18(64.00) | 240.86(163.24) | 238.18(128.90) | 246.11(215.96) | 259.67(170.06) | 204.00(142.72) |
| Helicity density [m/s2] | 8.18(4.47) | 9.70(5.40) | 9.22(4.56) | 10.63(6.66) | 9.33(5.78) | 10.43(4.48) |
| Viscous dissipation [13/s2] | 6.25(3.36) | 7.66(4.22) | 7.29(3.95) | 8.37(4.64) | 7.34(4.38) | 8.28(3.84) |
| Energy loss [uW] | 0.39(0.22) | 0.47(0.27) | 0.45(0.26) | 0.51(0.30) | 0.46(0.28) | 0.50(0.26) |
| Kinetic energy [uJ] | 2.01(1.34) | 2.15(1.04) |
The mark (*) and bold numbers shows if the parameter is lower in the BAV than volunteer groups.
Figure 4ROC curves for the AAo; (A) HV vs. all BAV; (B) HV vs. BAV-RL; (C) HV vs. BAV-RN; (D) HV vs. BAV-Non-AAoD; (E) HV vs. BAV-AAoD. The parameters of the legend are the nine parameters with bigger area under the curve (AUC) values.
Figure 5Spearman's correlation coefficient values for patients with BAV, BAV-RN, BAV-RL, BAV-AAoD, and BAV-Non-AAoD are reported. These values were grouped as good correlation (red box, Spearman's correlation between |0.5| and |0.7|), strong correlation (blue box, Spearman's correlation between |0.7| and |0.9|), and excellent correlation (green box, Spearman's correlation above |0.9|). The minus sign indicates a negative correlation.
Figure 6(A) A patient with maximum values of diameter and regurgitation fraction; (B) a patient with maximum WSSC and axial circulation; (C) a patient with positive axial circulation; and (D) one case with negative axial circulation.